IL-5/IL-13 drive NLRP3 inflammasome-mediated, steroid-resistant AHR in a model of obesity-associated asthma

J. Pinkerton (London, United Kingdom), R. Kim (Newcastle, Australia), A. Brown (Newcastle, Australia), B. Rae (Newcastle, Australia), J. Mayall (Newcastle, Australia), M. Ali (Newcastle, Australia), M. Starkey (Newcastle, Australia), A. Robertson (Brisbane, Australia), L. Wood (Newcastle, Australia), M. Cooper (Brisbane, Australia), L. O'Neill (Dublin, Ireland), P. Hansbro (Sydney, Australia), J. Horvat (Newcastle, Australia)

Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases
Session: Understanding the mechanisms underlying airway diseases
Session type: Poster Discussion
Number: 3345
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Pinkerton (London, United Kingdom), R. Kim (Newcastle, Australia), A. Brown (Newcastle, Australia), B. Rae (Newcastle, Australia), J. Mayall (Newcastle, Australia), M. Ali (Newcastle, Australia), M. Starkey (Newcastle, Australia), A. Robertson (Brisbane, Australia), L. Wood (Newcastle, Australia), M. Cooper (Brisbane, Australia), L. O'Neill (Dublin, Ireland), P. Hansbro (Sydney, Australia), J. Horvat (Newcastle, Australia). IL-5/IL-13 drive NLRP3 inflammasome-mediated, steroid-resistant AHR in a model of obesity-associated asthma. 3345

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The roles of Th2 cytokines and their signaling pathways in the pathogenesis of non-eosinophilic asthma enhanced by dsRNA
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006


Caspase-1 induces upstream Th2-cytokines IL-33 and TSLP and eosinophilia at viral induced asthma exacerbations
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016

NLRP3 inflammasome-mediated, IL-1β-dependent inflammatory responses drive steroid-resistant asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016

Interleukin-17 cytokine signalling in patients with asthma
Source: Eur Respir J 2014; 44: 1319-1331
Year: 2014



A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 568s
Year: 2002

IL-10 and IL-1ra mediates OVA-induced Th2 airway allergic response at short and long-term
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013


HDM-challenged mice exhibit impaired interferon response to TLR3 ligand in a murine model of viral asthma exacerbation
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model
Source: ERJ Open Res, 3 (4) 00047-2017; 10.1183/23120541.00047-2017
Year: 2017



Elevated expression of the NLRP3 inflammasome in neutrophilic asthma
Source: Eur Respir J 2014; 43: 1067-1076
Year: 2014



IL-17F, rather than IL-17A, underlies airway inflammation in a steroid-insensitive toluene diisocyanate-induced asthma model
Source: Eur Respir J, 53 (4) 1801510; 10.1183/13993003.01510-2018
Year: 2019



Aerobic exercise reduces pulmonary inflammation in diet-induced obesity in a HDM model of asthma through adipokines, IL-10, IL-17 and IL-23 signaling
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015


Interleukin-33 and Th2 cytokines correlate in acute asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016

Overexpression of suppressor of cytokine signaling-5 augments eosinophilic inflammation in an asthma model
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004

High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Role of IL-33 signaling in pollutant-induced allergic airway inflammation
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018


The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007


Resolvin E3 dampens asthmatic inflammation in a murine model through IL-23 pathway
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019



IL-37 requires IL18Rα and SIGIRR to diminish experimental allergic airway inflammation in mice
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

Analysis of cytokine signaling through the STAT6 activation in patients with atopic steroid-free asthma
Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy
Year: 2007